207 related articles for article (PubMed ID: 36072510)
1. Pyruvate Kinase Deficiency: Current Challenges and Future Prospects.
Fattizzo B; Cavallaro F; Marcello APML; Vercellati C; Barcellini W
J Blood Med; 2022; 13():461-471. PubMed ID: 36072510
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of mitapivat for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency.
Song AB; Al-Samkari H
Expert Rev Hematol; 2022 Oct; 15(10):875-885. PubMed ID: 36124781
[TBL] [Abstract][Full Text] [Related]
3. Mitapivat: A Quinolone Sulfonamide to Manage Hemolytic Anemia in Adults With Pyruvate Kinase Deficiency.
Wills J; Horenstein M; Kim A; Silva MA; Dima L
Am J Ther; 2023 Sep-Oct 01; 30(5):e433-e438. PubMed ID: 37713687
[TBL] [Abstract][Full Text] [Related]
4. Updates and advances in pyruvate kinase deficiency.
Luke N; Hillier K; Al-Samkari H; Grace RF
Trends Mol Med; 2023 May; 29(5):406-418. PubMed ID: 36935283
[TBL] [Abstract][Full Text] [Related]
5. Mitapivat: A Review in Pyruvate Kinase Deficiency in Adults.
Zhuang-Yan A; Shirley M
Drugs; 2023 Nov; 83(17):1613-1620. PubMed ID: 37991635
[TBL] [Abstract][Full Text] [Related]
6. Pyruvate kinase activators for treatment of pyruvate kinase deficiency.
Grace RF
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):97-106. PubMed ID: 38066940
[TBL] [Abstract][Full Text] [Related]
7. Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.
Grace RF; Bianchi P; van Beers EJ; Eber SW; Glader B; Yaish HM; Despotovic JM; Rothman JA; Sharma M; McNaull MM; Fermo E; Lezon-Geyda K; Morton DH; Neufeld EJ; Chonat S; Kollmar N; Knoll CM; Kuo K; Kwiatkowski JL; Pospíšilová D; Pastore YD; Thompson AA; Newburger PE; Ravindranath Y; Wang WC; Wlodarski MW; Wang H; Holzhauer S; Breakey VR; Kunz J; Sheth S; Rose MJ; Bradeen HA; Neu N; Guo D; Al-Sayegh H; London WB; Gallagher PG; Zanella A; Barcellini W
Blood; 2018 May; 131(20):2183-2192. PubMed ID: 29549173
[TBL] [Abstract][Full Text] [Related]
8. Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias.
Al-Samkari H; van Beers EJ
Ther Adv Hematol; 2021; 12():20406207211066070. PubMed ID: 34987744
[TBL] [Abstract][Full Text] [Related]
9. How we manage patients with pyruvate kinase deficiency.
Grace RF; Mark Layton D; Barcellini W
Br J Haematol; 2019 Mar; 184(5):721-734. PubMed ID: 30681718
[TBL] [Abstract][Full Text] [Related]
10. Congenital Hemolytic Anemias: Is There a Role for the Immune System?
Zaninoni A; Fermo E; Vercellati C; Marcello AP; Barcellini W; Bianchi P
Front Immunol; 2020; 11():1309. PubMed ID: 32655575
[TBL] [Abstract][Full Text] [Related]
11. Pyruvate Kinase Deficiency Causing Priapism.
Shankar VH; Adithya-Sateesh B; Gousy N; Ayele G; Petursson F; Atalay R; Michael M
Case Rep Hematol; 2023; 2023():6503311. PubMed ID: 37197195
[TBL] [Abstract][Full Text] [Related]
12. Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency.
van Beers EJ; Al-Samkari H; Grace RF; Barcellini W; Glenthøj A; DiBacco M; Wind-Rotolo M; Xu R; Beynon V; Patel P; Porter JB; Kuo KHM
Blood Adv; 2024 May; 8(10):2433-2441. PubMed ID: 38330179
[TBL] [Abstract][Full Text] [Related]
13. Management of pyruvate kinase deficiency in children and adults.
Grace RF; Barcellini W
Blood; 2020 Sep; 136(11):1241-1249. PubMed ID: 32702739
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Demographic Characteristics of Pyruvate Kinase Deficiency Patients: A Comprehensive Case Series Analysis.
Nasiri A; Haroon A; Alzahrani H
Cureus; 2024 May; 16(5):e60035. PubMed ID: 38736761
[TBL] [Abstract][Full Text] [Related]
15. A novel homozygous missense variant p.D339N in the PKLR gene correlates with pyruvate kinase deficiency in a Pakistani family: a case report.
Rehman AU; Rashid A; Hussain Z; Shah K
J Med Case Rep; 2022 Feb; 16(1):66. PubMed ID: 35168679
[TBL] [Abstract][Full Text] [Related]
16. Pyruvate kinase deficiency in children.
Chonat S; Eber SW; Holzhauer S; Kollmar N; Morton DH; Glader B; Neufeld EJ; Yaish HM; Rothman JA; Sharma M; Ravindranath Y; Wang H; Breakey VR; Sheth S; Bradeen HA; Al-Sayegh H; London WB; Grace RF
Pediatr Blood Cancer; 2021 Sep; 68(9):e29148. PubMed ID: 34125488
[TBL] [Abstract][Full Text] [Related]
17. Mitapivat for sickle cell disease and thalassemia.
Pilo F; Angelucci E
Drugs Today (Barc); 2023 Mar; 59(3):125-134. PubMed ID: 36847623
[TBL] [Abstract][Full Text] [Related]
18. A Family Affected by a Life-Threatening Erythrocyte Defect Caused by Pyruvate Kinase Deficiency With Normal Iron Status: A Case Report.
Maciak K; Adamowicz-Salach A; Poznanski J; Gora M; Fronk J; Burzynska B
Front Genet; 2020; 11():560248. PubMed ID: 33193643
[TBL] [Abstract][Full Text] [Related]
19. [Congenital hemolytic anemias due to erythrocyte membrane and enzyme defects].
Génevaux F; Bertsch A; Wiederer L; Eber S
Dtsch Med Wochenschr; 2022 Sep; 147(19):1266-1276. PubMed ID: 36126925
[TBL] [Abstract][Full Text] [Related]
20. Identification and in silico characterization of a novel PKLR genotype in a Turkish newborn.
Canu G; De Paolis E; Righino B; Mazzuccato G; De Paolis G; Capoluongo E; De Rosa MC; Urbani A; Gunes AM; Minucci A
Mol Biol Rep; 2020 Oct; 47(10):8311-8315. PubMed ID: 32974842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
